stockrowNortech Systems Incorporated
NSYS Healthcare Medical Devices
Nortech Systems Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $118.4 million, down 7.62% from fiscal 2024.
- Revenue
- +9.34%
- EPS
- −8.33%
- Free cash flow
- −1,567.2%
- Total debt
- −79.0%
Quarter to June 2026, against a year earlier
Follow NSYS
Alert me
Nortech Systems Incorporated (NSYS) EV/Sales
As of 5 November 2026, Nortech Systems Incorporated (NSYS) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.2× (December 2025) to 0.5× (July 2022); the current reading is higher than 60% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.2× | (39.82%) |
| FY2024 | 0.3× | 23.19% |
| FY2023 | 0.2× | (16.33%) |
| FY2022 | 0.3× | (10.68%) |
| FY2021 | 0.3× | 23.25% |
| FY2020 | 0.3× | 9.99% |
| FY2019 | 0.2× | 15.28% |
| FY2018 | 0.2× | (8.16%) |
| FY2017 | 0.2× | 9.04% |
| FY2016 | 0.2× | (8.62%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 0.4× | 28.27% |
| Mar 2026 | 0.3× | 59.70% |
| Dec 2025 | 0.2× | (20.38%) |
| Sep 2025 | 0.2× | (30.89%) |
| 42 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NNOX Nano-X Imaging Ltd. compare | −0.5× |
| NSYS Nortech Systems Incorporated | 0.2× |
| XTNT Xtant Medical Holdings, Inc. compare | 0.5× |
| CVRX CVRx, Inc. compare | 0.7× |
| RPID Rapid Micro Biosystems, Inc. compare | 0.8× |
| TELA TELA Bio, Inc. compare | 1.0× |
| QTI QT Imaging Holdings, Inc. compare | 1.3× |
| NSPR InspireMD, Inc. compare | 2.5× |
| ELUT Elutia Inc. compare | 3.4× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)